LENZ Therapeutics Dividends
| LENZ Stock | 37.30 1.05 2.90% |
Dividend Paid And Capex Coverage Ratio is likely to drop to -8.71 in 2024. LENZ Therapeutics' past performance could be the main factor of why investors trade LENZ Therapeutics stock today. Investors should clearly understand every aspect of the LENZ Therapeutics dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest LENZ Therapeutics' dividend schedule and payout information. LENZ Therapeutics dividends can also provide a clue to the current valuation of LENZ Therapeutics.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | (8.29) | (8.71) |
LENZ |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in LENZ Therapeutics must own a stock before its ex-dividend date to receive its next dividend.
LENZ Therapeutics Expected Dividend Income Per Share
Dividend payment represents part of LENZ Therapeutics' profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in LENZ Therapeutics. LENZ Therapeutics' board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$1.68 Bottom Scenario | 2.4 | $3.12 Top Scenario |
One Year
LENZ Therapeutics expected dividend income per share adjusted for ongoing price standard deviation
LENZ Therapeutics Past Distributions to stockholders
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LENZ Therapeutics. If investors know LENZ will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LENZ Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.74) | Return On Assets (0.77) | Return On Equity (1.58) |
The market value of LENZ Therapeutics is measured differently than its book value, which is the value of LENZ that is recorded on the company's balance sheet. Investors also form their own opinion of LENZ Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is LENZ Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LENZ Therapeutics' market value can be influenced by many factors that don't directly affect LENZ Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LENZ Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if LENZ Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LENZ Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.